期刊文献+

载酯蛋白A—I与急性呼吸道感染的关系

The clinical significance of serum apolipoprotein A-I to the diagnosis of acute respiratory infection
原文传递
导出
摘要 目的探讨急性呼吸道感染患者血清载酯蛋白A—I(ApoA-I)变化及临床意义。方法2006年12月至2007年7月入住上海交通大学附属第一人民医院急诊ICU及急诊观察室急性呼吸道感染患者为试验组(44例),根据降钙素原(PCT)的质量浓度进行分组,分为PCT〈0.5ng/ml组,0.5ng/ml≤PCT〈2ng/ml组,PCT≥2ng/ml组。41例健康体检者为对照组。试验组和对照组均在入院24h内测定静脉血中ApoA—I、PCT、C反应蛋白(CRP)和白蛋白水平。统计学方法计量资料用均数±标准差(-↑x±s)表示,应用SPSS12.0软件进行统计学分析,计量资料的比较采用t检验及方差分析,相关性分析采用直线相关分析,P〈0.05为差异具有统计学意义。结果随着PCT质量浓度增加,ApoA—I和血清白蛋白值越低而CRP值越高(P〈0.05)。结论ApoA—I与呼吸道感染的严重程度呈正相关,在较严重的呼吸道感染ApoA-I具有一定的诊断价值,表明这类患者存在脂质代谢紊乱。 Objective To investigate the changes of serum apolipoprotein A-I and its clinical significance to acute respiratory infection. Method Totally 44 patients with acute respiratory infection were divided into three groups according to various concentration of serum apolipoprotein A-I. They were procalcitonin(PCF) 〈 0.5 ng/ml group,0.5 ng/ml≤PCF〈 2 ng/ml group and PCF≥2 ng/ml group. We measured apolipoprotein A-I,C-reactive protein, procalcitonin and albumin within 24 hours after admission. Results With the increase of serum PCT, the production of ApoA-I and albumin were down-regulated, while CRP up-regulated. Conclusions Apolipoprotein A-I has a sound relationship with the acute respiratory infection. It can be used as one of the diagnostic criteria in severe infection patients who have disorders of lipometabolism.
出处 《中华急诊医学杂志》 CAS CSCD 2008年第5期525-527,共3页 Chinese Journal of Emergency Medicine
关键词 载酯蛋白A—I 降钙素原 C反应蛋白 白蛋白 ApolipopmteinA-I(ApoA-I) Procalcitonin(PCT) C reactive protein(CRP) Albumin
  • 相关文献

参考文献11

  • 1王秀洁,董广涛.载脂蛋白AⅠ与全身炎症反应综合征[J].中华急诊医学杂志,2007,16(3):330-332. 被引量:4
  • 2Vincent JL, Moreno R, Takala J, et al. The SOFA ( Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine [J]. Intensive Care Med, 1996, 22 (7) :707-710.
  • 3俞凤,赵良,管军,许永华,杨兴易,陈德昌,林兆奋,单红卫,马钧,郭昌星,李文放,刘军英.SOFA评分对多器官功能障碍综合征患者的预后评价作用[J].中国危重病急救医学,2002,14(8):481-484. 被引量:33
  • 4Chenaud C, Merlani PG, Roux-Lombard P, et al. Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation [ J ]. Crit Care Med, 2004, 32 ( 3 ) : 632- 637.
  • 5Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guiddines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992,101 (6) : 1644-1655.
  • 6Madan B, Ghosh BC. Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock[J]. Shock, 2003,19(1):91-96.
  • 7Sprong T, Netea MG, van der Ley P, et al. Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitldes LPS, and complete Gram-negative bacteria [ J ]. Lipid Res, 2004,45 ( 4 ) : 742-749.
  • 8Gordon BR, Parker TS, Levine DM, et al. Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients [J] .Crit CarMed,2001,29 (8) : 1563-1568.
  • 9Van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis[J]. Crit Care Med,2003,31 (5) : 1359-1366.
  • 10Kudsk KA, Tolley EA, DeWitt RC, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications [J]. Parenter Enteral Nutr,2003,27( 1 ) : 1-9.

二级参考文献31

  • 1王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准(经庐山’95全国危重病急救医学学术会讨论通过)[J].中国危重病急救医学,1995,7(6):346-347. 被引量:1424
  • 2Furlaneto C,J, Ribeiro FP, Hatanaka E, et al. Apolipoproteins A Ⅰand A Ⅱ downregulate neutrophil functions [J]. Lipids, 2002, 37(9): 925-928.
  • 3Ulevitch RJ, Tobias PS. Recognization of gram-negative bacteria and endotoxin by the innate immune system [ J]. Curt Opm lmunol,1999, 1 1 (1): 19-22.
  • 4Yang RB, Mark MR, Gray A, et al. ToU-like receptor-2 mediates lipopolysac Chafides-induced cellular signalling [J]. Nature, 1998,395 (6699) : 284-288.
  • 5Sprong T, Netea MG, van der Ley P, et al. Human lipoproteins have divergent neutralizing effects on E. coli LPS, N. meningitidis LPS, and complete Gram-negative bacteria [J]. J Lipid Res, 2004,45 (4): 742-749.
  • 6Brandenburg K, Jurgens G, Andra J, et al. Biophysical characterization of the interaction of high density lipoprotein (HDL) with endotoxins [J]. Eur J Biochem, 2001, 269 (23) : 5972-5981.
  • 7Levels JH, Abraham PR, van den Ende A, et al. Distribution and kinetics of lipoprotein-bound endotoxin [ J ]. Infect J lmmunol,2001, 69 (5) : 2821-2821.
  • 8Ma J, Liao XL, Lou B, et al. Role of Apolipoprotem A 1 in protecting against endotoxm toxicity [J]. Acta Biochim Biophys Sin(Shanghai), 2004, 36 (6): 419-424.
  • 9van Leeuwen H j, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis [J]. Cfit Care Med, 2003,31 (5) : 1359-1366.
  • 10Chenaud C, Medam PG, Roux-Lombard P, et al. Low apolipoprotem A Ⅰ level at intensive care unit admission and systemic inflammatory response syndrome exacerbation [J]. Crlt Care Med,2004, 32 (3): 632-637.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部